2010 - ANZSBT History Project

Next Generation Sequencing extends potential role & capability of blood group genotyping systems.

Commercial automated genotyping platforms suitable for transfusion services made available.

Interference with antiglobulin tests by therapeutic monoclonal antibodies & the resolution thereof reported: 2015 – CD38, 2019 – CD47

The Australian & New Zealand Society of Blood Transfusion (ANZSBT) aims to engage with stakeholders in all areas of transfusion through communication, representation and advocacy.

Get Involved

Explore

Suggest an Edit

The History Committee has made every effort to source & record accurate facts, dates & figures.

Source materials, especially older texts, have been of variable integrity & we welcome notification of any corrections which will improve the accuracy of our historical story.

Suggest an edit